...
首页> 外文期刊>Surgical infections >Differences in Bile Microbiology and Antibiotic Resistances between Liver Transplant Recipients and Non-Transplant Patients
【24h】

Differences in Bile Microbiology and Antibiotic Resistances between Liver Transplant Recipients and Non-Transplant Patients

机译:肝移植受者与非移植患者的胆汁微生物学和抗生素抗性的差异

获取原文
获取原文并翻译 | 示例

摘要

Background: Treatment of biliary infection in liver transplant (LT) recipients is a challenge, especially because of ineffectiveness of the antibiotic agents otherwise recommended for non-transplant populations. We aimed to understand the factors underlying the choice of antibiotic therapy.Patients and Methods: A total of 373 bile cultures from LT recipients with biliary complications (n = 127; LT group) and from a non-transplant population that underwent cholecystectomy for acute cholecystitis (n = 246; non-transplant group) between January 2009 and December 2018, were investigated.Results: Polymicrobial cultures (13.4% vs. 1.6%; p 0.001), Enterococcus faecium (26.0% vs. 8.5%; p 0.001), and Pseudomonas (13.4% vs. 4.1%; p = 0.001) in the LT group, and non-faecium enterococci (3.9% vs. 18.3%; p 0.001) and Enterobacteriales (40.2% vs. 54.9%; p = 0.007), especially Escherichia (11.0% vs. 29.7%; p 0.001), in the non-transplant group, showed higher abundance. Most of the antibiotic agents recommended as initial antibiotic therapy for the non-transplant population as per previous guidelines were not effective in LT recipients. The incidences of Enterococcus faecium (14.9% vs. 32.5%; p = 0.029) in the LT recipients with model for end-stage liver disease (MELD) score 12 and non-faecium enterococci (8.5% vs. 1.3%; p = 0.042) in those with MELD score ≤12 were higher than those in the other group. The incidence of Enterobacteriales increased over time after LT (p = 0.048) and was similar to that in the non-transplant group after one year of LT. Bile micro-organisms in LT recipients, resistant to most antibiotic agents, especially soon after LT changed over time and became similar to those in the non-transplant group after one year of LT.Conclusions: Antibiotic therapy for biliary infection in LT recipients should be different from that in non-transplant populations, considering clinical factors such as the time interval after LT and MELD score.
机译:背景:肝脏移植(LT)受者的治疗胆道感染是一种挑战,特别是因为抗生素试剂的无效,否则推荐用于非移植种群。我们旨在了解抗生素疗法选择的因素。患者和方法:来自LT受者的373种胆汁培养物,具有胆汁并发症(n = 127; LT组),并且来自未移植的群体胆囊切除术治疗急性胆囊炎(N = 246; 2018年1月至2018年12月之间的非移植组)进行了研究。结果:多发性培养物(13.4%vs.1.6%; P <0.001),肠球菌粪便(26.0%与8.5%; P&LT LT基团中的假鼠(13.4%)(13.4%vs.4.1%; p = 0.001),非粪便肠球菌(3.9%vs.18.3%; p <0.001)和肠杆菌(40.2%vs.54.9%) ; P = 0.007),特别是大肠杆菌(11.0%与29.7%; P <0.001),在非移植组中,表现出更高的丰度。根据以前的指导原则,大多数抗生素剂推荐为未移植群体的初始抗生素治疗无效。肠球菌粪便(14.9%对32.5%; p = 0.029),具有终末期肝病(Meld)得分& 12和非粪便肠球菌(8.5%vs.1.3%; p在融合得分≤12的那些中= 0.042)高于其他组中的那些。在LT(P = 0.048)后,肠的发生率随着时间的推移而增加,并且在LT的一年后与非移植组中的相似。 LT受者的胆汁微生物,耐大多数抗生素药剂,特别是在LT随时间变化后很快并且在一年后发生了类似的那些,并且在LT.Conclusions中的抗生素治疗应该是胆道感染的抗生素治疗与非移植群体不同,考虑到LT和MELD评分之后的时间间隔之类的临床因素。

著录项

  • 来源
    《Surgical infections 》 |2021年第7期| 741-751| 共11页
  • 作者单位

    Department of Surgery College of Medicine Department of Internal Medicine Chung-Ang University College of Medicine;

    Department of Surgery College of Medicine Department of Internal Medicine Chung-Ang University College of Medicine;

    Department of Surgery College of Medicine Department of Internal Medicine Chung-Ang University College of Medicine;

    Department of Surgery College of Medicine Department of Internal Medicine Chung-Ang University College of Medicine;

    Division of Infectious Diseases Department of Internal Medicine Chung-Ang University College of Medicine;

    Department of Surgery College of Medicine Seoul National University Bundang Hospital;

    Department of Surgery College of Medicine Seoul National University;

    Department of Surgery College of Medicine Soonchunhyang University;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    antibiotic therapy; bacteremia; bile micro-organisms; biliary infection; liver transplant;

    机译:抗生素治疗;菌血症;胆汁微生物;胆道感染;肝移植;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号